Peter Kalhs

4.6k total citations
119 papers, 3.3k citations indexed

About

Peter Kalhs is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Peter Kalhs has authored 119 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Hematology, 24 papers in Oncology and 20 papers in Immunology. Recurrent topics in Peter Kalhs's work include Hematopoietic Stem Cell Transplantation (67 papers), Acute Myeloid Leukemia Research (24 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Peter Kalhs is often cited by papers focused on Hematopoietic Stem Cell Transplantation (67 papers), Acute Myeloid Leukemia Research (24 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Peter Kalhs collaborates with scholars based in Austria, Germany and Nigeria. Peter Kalhs's co-authors include Hildegard Greinix, Werner Rabitsch, Margit Mitterbauer, Robert Knobler, Nina Worel, Klaus Lechner, Felix Keil, Gottfried Fischer, Beatrix Volc‐Platzer and Axel Schulenburg and has published in prestigious journals such as The Lancet, Blood and Annals of Internal Medicine.

In The Last Decade

Peter Kalhs

118 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kalhs Austria 34 2.4k 1.1k 573 478 472 119 3.3k
Giovanna Giorgiani Italy 33 2.0k 0.9× 908 0.9× 575 1.0× 629 1.3× 544 1.2× 93 2.9k
Hiroyasu Ogawa Japan 33 1.8k 0.8× 735 0.7× 882 1.5× 442 0.9× 517 1.1× 153 3.0k
Franco Locatelli Italy 22 1.9k 0.8× 704 0.7× 438 0.8× 826 1.7× 365 0.8× 46 2.5k
KM Sullivan United States 29 2.7k 1.1× 949 0.9× 755 1.3× 564 1.2× 599 1.3× 50 3.4k
Adrian Goycoolea 2 1.6k 0.7× 556 0.5× 796 1.4× 424 0.9× 381 0.8× 3 2.8k
H. Kent Holland United States 22 2.1k 0.9× 1.0k 1.0× 921 1.6× 795 1.7× 501 1.1× 100 3.1k
Joseph P. Uberti United States 27 1.5k 0.6× 803 0.8× 871 1.5× 762 1.6× 291 0.6× 159 3.0k
Rakesh Mehra United States 26 2.4k 1.0× 1.0k 1.0× 1.1k 1.8× 638 1.3× 490 1.0× 61 3.2k
Taner Demirer Türkiye 31 2.2k 0.9× 763 0.7× 1.2k 2.0× 512 1.1× 261 0.6× 101 3.2k
A Eldor Israel 17 3.1k 1.3× 1.2k 1.2× 913 1.6× 711 1.5× 572 1.2× 40 3.8k

Countries citing papers authored by Peter Kalhs

Since Specialization
Citations

This map shows the geographic impact of Peter Kalhs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kalhs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kalhs more than expected).

Fields of papers citing papers by Peter Kalhs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kalhs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kalhs. The network helps show where Peter Kalhs may publish in the future.

Co-authorship network of co-authors of Peter Kalhs

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kalhs. A scholar is included among the top collaborators of Peter Kalhs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kalhs. Peter Kalhs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strobl, Johanna, Ram Vinay Pandey, Thomas Krausgruber, et al.. (2020). Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease. Journal of Investigative Dermatology. 140(11). 2188–2198. 8 indexed citations
2.
3.
4.
Robak, Oliver, Zoya Kuzmina, Andreas Winkler, et al.. (2016). Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation. Croatian Medical Journal. 57(3). 255–265.
5.
Vogl, Ursula, Gerda Leitner, Assunta Dal‐Bianco, et al.. (2016). Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation. Wiener klinische Wochenschrift. 128(9-10). 384–386. 2 indexed citations
6.
Worel, Nina, Gerda Leitner, Andrea Wagner, et al.. (2008). Therapeutic apheresis in hematopoietic cell transplantation.. PubMed. 25(4). 164–71. 1 indexed citations
7.
Leitner, Gerda, et al.. (2008). Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study. Bone Marrow Transplantation. 43(5). 357–363. 17 indexed citations
8.
Greinix, Hildegard, et al.. (2007). A Single-Center Pilot Validation Study of a New Chronic GVHD Skin Scoring System. Biology of Blood and Marrow Transplantation. 13(6). 715–723. 35 indexed citations
9.
Greinix, Hildegard, Robert Knobler, Nina Worel, et al.. (2006). The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.. PubMed. 91(3). 405–8. 161 indexed citations
10.
Schulenburg, Axel, Karl Turetschek, Fritz Wrba, et al.. (2004). Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Annals of Hematology. 83(2). 101–106. 46 indexed citations
11.
Agis, Hermine, Christine Mannhalter, Wolfgang R. Sperr, et al.. (2004). Detection of Trisomy 8 in Donor-Derived Ph−Cells in a Patient with Ph+Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation. Leukemia & lymphoma. 45(7). 1453–1458. 6 indexed citations
12.
Greinix, Hildegard, Ingrid Faé, Barbara Schneider, et al.. (2004). Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplantation. 35(1). 57–62. 45 indexed citations
13.
Kerschan‐Schindl, Katharina, Margit Mitterbauer, Wolfgang Füreder, et al.. (2004). Bone metabolism in patients more than five years after bone marrow transplantation. Bone Marrow Transplantation. 34(6). 491–496. 22 indexed citations
14.
15.
Leitner, Gerda, et al.. (2003). Influence of human platelet antigen match on the success of stem cell transplantation after myeloablative conditioning. Bone Marrow Transplantation. 32(8). 821–824. 5 indexed citations
16.
Rabitsch, Werner, Paul Knöbl, Erika Prinz, et al.. (2003). Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption. Bone Marrow Transplantation. 32(10). 1015–1019. 26 indexed citations
17.
18.
Worel, Nina, Hildegard Greinix, J Ackermann, et al.. (2001). Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma. Annals of Hematology. 80(6). 345–348. 23 indexed citations
19.
Worel, Nina, Hildegard Greinix, M. Kurz, et al.. (2000). Regeneration of erythropoiesis after related‐ and unrelated‐donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion. 40(5). 543–550. 90 indexed citations
20.
Gaiger, Alexander, Diethart Schmid, Georg Heinze, et al.. (1998). Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia. Leukemia. 12(12). 1886–1894. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Giorgiani Breakdown of academic impact, for papers by Hiroyasu Ogawa Breakdown of academic impact, for papers by Franco Locatelli Breakdown of academic impact, for papers by KM Sullivan Breakdown of academic impact, for papers by Adrian Goycoolea Breakdown of academic impact, for papers by H. Kent Holland Breakdown of academic impact, for papers by Joseph P. Uberti Breakdown of academic impact, for papers by Rakesh Mehra Breakdown of academic impact, for papers by Taner Demirer Breakdown of academic impact, for papers by A Eldor
Rankless by CCL
2026